2,276 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Wealth Management Nebraska

Wealth Management Nebraska bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 2,276 shares of the biotechnology company’s stock, valued at approximately $1,353,000. Axon Enterprise makes up about 0.2% of Wealth Management Nebraska’s portfolio, making the stock its 22nd largest position.

Other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. increased its stake in shares of Axon Enterprise by 234.5% in the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company’s stock worth $116,000 after purchasing an additional 204 shares in the last quarter. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise during the third quarter valued at about $221,000. Sequoia Financial Advisors LLC increased its position in Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after buying an additional 81 shares in the last quarter. Signaturefd LLC raised its stake in shares of Axon Enterprise by 16.3% in the third quarter. Signaturefd LLC now owns 655 shares of the biotechnology company’s stock worth $262,000 after buying an additional 92 shares during the period. Finally, Private Advisor Group LLC lifted its position in shares of Axon Enterprise by 19.8% during the 3rd quarter. Private Advisor Group LLC now owns 12,382 shares of the biotechnology company’s stock valued at $4,948,000 after buying an additional 2,043 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock worth $5,631,561 in the last quarter. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Trading Down 5.3 %

Shares of AXON stock opened at $513.22 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $39.13 billion, a price-to-earnings ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 12-month low of $265.32 and a 12-month high of $715.99. The stock’s 50-day moving average price is $619.94 and its 200-day moving average price is $517.11.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on AXON shares. Robert W. Baird increased their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. JMP Securities increased their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. TD Cowen began coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a research note on Thursday. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.